// App-Quantinova.ai

1264-225 : CYP2C19 LOSS-OF-FUNCTION ALLELE GENOTYPING COMBINED WITH THROMBELASTOGRAPH PLATELET-MAPPING ASSAY IS AN INDEPENDENT PREDICTOR OF ADVERSE CARDIOVASCULAR OUTCOMES IN CHINESE PATIENTS TREATED WITH CLOPIDOGREL UNDERGOING CORONARY STENTING

Researchers

Presenter

  • Xiao-Fang Tang

Principal Investigators

  • Yue-Jin Yang

  • Jin-Qing Yuan

  • Jue Chen

  • Jia-Hui Zhang

  • Zhan Gao

  • Run-Lin Gao

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Cytochrome P450 2C19

Drug/Treatment

  • Clopidogrel bisulfate

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved